KCM
ANGO icon

Kennedy Capital Management’s AngioDynamics ANGO Stock Holding History

Kennedy Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Buy
196,813
+3,526
+2% +$38.2K 0.05% 410
2025
Q4 		$2.48M Sell
193,287
-1,233
-0.6% -$15.2K 0.05% 398
2025
Q3 		$2.17M Sell
194,520
-674
-0.3% -$6.5K 0.05% 436
2025
Q2 		$1.94M Buy
195,194
+13,932
+8% +$136K 0.05% 446
2025
Q1 		$1.7M Sell
181,262
-1,056
-0.6% -$11.1K 0.04% 450
2024
Q4 		$1.67M Sell
182,318
-4,653
-2% -$34.2K 0.04% 541
2024
Q3 		$1.45M Sell
186,971
-2,439
-1% -$17.6K 0.03% 556
2024
Q2 		$1.15M Sell
189,410
-826
-0.4% -$5.1K 0.02% 577
2024
Q1 		$1.12M Buy
190,236
+154,002
+425% +$915K 0.02% 613
2023
Q4 		$284K Sell
36,234
-617
-2% -$4.28K 0.01% 655
2023
Q3 		$269K Hold
36,851
– – 0.01% 640
2023
Q2 		$384K Hold
36,851
– – 0.01% 616
2023
Q1 		$381K Hold
36,851
– – 0.01% 579
2022
Q4 		$507K Sell
36,851
-5
-0% -$70 0.01% 553
2022
Q3 		$754K Sell
36,856
-70
-0.2% -$1.54K 0.02% 515
2022
Q2 		$715K Sell
36,926
-359
-1% -$7.35K 0.02% 511
2022
Q1 		$803K Sell
37,285
-5,803
-13% -$132K 0.02% 518
2021
Q4 		$1.19M Sell
43,088
-4,372
-9% -$121K 0.03% 497
2021
Q3 		$1.23M Sell
47,460
-39,609
-45% -$1.06M 0.03% 506
2021
Q2 		$2.36M Buy
+87,069
New +$2.13M 0.05% 473
2020
Q1 		– Sell
-311,263
Closed -$4.98M – 664
2019
Q4 		$4.98M Sell
311,263
-20,787
-6% -$317K 0.12% 332
2019
Q3 		$6.12M Sell
332,050
-18,941
-5% -$370K 0.15% 241
2019
Q2 		$6.91M Sell
350,991
-6,861
-2% -$140K 0.16% 232
2019
Q1 		$8.18M Buy
357,852
+14,448
+4% +$314K 0.19% 189
2018
Q4 		$6.91M Sell
343,404
-27,523
-7% -$570K 0.17% 217
2018
Q3 		$8.06M Sell
370,927
-358,504
-49% -$7.96M 0.15% 244
2018
Q2 		$16.2M Buy
729,431
+49,746
+7% +$1.02M 0.3% 74
2018
Q1 		$11.7M Buy
679,685
+556,880
+453% +$9.29M 0.23% 128
2017
Q4 		$2.04M Sell
122,805
-1,385
-1% -$23.6K 0.04% 617
2017
Q3 		$2.12M Buy
+124,190
New +$2.09M 0.04% 609
2016
Q2 		– Sell
-47,909
Closed -$589K – 707
2016
Q1 		$589K Buy
+47,909
New +$529K 0.01% 689
2015
Q1 		– Sell
-135,931
Closed -$2.58M – 722
2014
Q4 		$2.58M Sell
135,931
-454,920
-77% -$7.71M 0.05% 533
2014
Q3 		$8.11M Buy
590,851
+28,750
+5% +$410K 0.16% 239
2014
Q2 		$9.18M Sell
562,101
-10,139
-2% -$147K 0.17% 217
2014
Q1 		$9.01M Sell
572,240
-24,459
-4% -$399K 0.17% 224
2013
Q4 		$10.2M Sell
596,699
-7,964
-1% -$123K 0.19% 186
2013
Q3 		$7.98M Sell
604,663
-66,620
-10% -$785K 0.15% 244
2013
Q2 		$7.57M Buy
+671,283
New +$7.14M 0.15% 253

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Kennedy Capital Management's ANGO Position: Q1 2026 in Review

Kennedy Capital Management increased its AngioDynamics (ANGO) stake by 1.8% in Q1 2026, buying an estimated $38.2K and bringing the position to 196,813 shares worth $2.24M. The position accounts for 0.05% of the portfolio, ranked #410.

Kennedy Capital Management first reported a position in ANGO in Q2 2013 and has held it in 38 quarters since. The position peaked at $16.2M in Q2 2018. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Kennedy Capital Management held 196,813 shares of AngioDynamics worth $2.24M as of Q1 2026.
  • Kennedy Capital Management bought 3,526 AngioDynamics shares in Q1 2026, an estimated $38.2K.
  • AngioDynamics made up 0.05% of Kennedy Capital Management's portfolio in Q1 2026, its #410 holding.
  • Kennedy Capital Management first reported a position in AngioDynamics in Q2 2013 and has held it in 38 quarters since.
  • Kennedy Capital Management's AngioDynamics position peaked at $16.2M in Q2 2018.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.